Science Explorer Back to mapMap
Discussion
Researcher · Reckitt Benckiser (United Kingdom) · United Kingdom

Imran Lodhi

Imran Lodhi publishes mostly in Infectious Diseases, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health, on topics such as Hormonal and reproductive studies, COVID-19 Clinical Research Studies and Pharmacological Receptor Mechanisms and Effects.

OpenAlex
World rank
#3,936,051
of 7,710,434 ranked researchers
Rank in United Kingdom
#252,706
of 367,258
Works
17
Citations
296
Citations per work
17.4
h-index
7
i10-index 6Top 83% in Infectious Diseases
Imran Lodhi

What does Imran Lodhi research?

Imran Lodhi's work is mostly in Medicine (31%), Biochemistry, Genetics and Molecular Biology (5%), Engineering (5%).

Everything else: 10 works · 59.4% of their workHealth Sciences: 5 works · 31.0% of their workMedicine: 5 works · 31.0% of their workInfectious Diseases: 2 works · 11.9% of their workEndocrinology, Diabetes and Metabolism: 2 works · 9.5% of their workOncology: 1 works · 4.8% of their workPsychiatry and Mental health: 1 works · 4.8% of their workLife Sciences: 1 works · 4.8% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 4.8% of their workMolecular Biology: 1 works · 4.8% of their workPhysical Sciences: 1 works · 4.8% of their workEngineering: 1 works · 4.8% of their workControl and Systems Engineering: 1 works · 4.8% of their workTHEIR WORKImran Lodhi17works
Life Sciences5%Physical Sciences5%Health Sciences31%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1059.4%
    1. Medicine531.0%
    1. Biochemistry, Genetics and Molecular Biology14.8%
    1. Engineering14.8%
  1. 1Infectious Diseases12% of their works
  2. 2Endocrinology, Diabetes and Metabolism10% of their works
  3. 3Psychiatry and Mental health5% of their works
  4. 4Oncology5% of their works
  5. 5Molecular Biology5% of their works
  6. 6Control and Systems Engineering5% of their works

Research topics

Which keywords describe Imran Lodhi's research?

The keywords of their largest research topics: ACE2 Receptor, SARS-CoV-2, Clinical Characteristics, Epidemiology, Hormone Therapy, Testosterone, Chaperone and Child Care.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. ACE2 Receptor52 topics
  2. SARS-CoV-252 topics
  3. Clinical Characteristics31 topic
  4. Epidemiology31 topic
  5. Hormone Therapy31 topic
  6. Testosterone31 topic
  7. Chaperone21 topic
  8. Child Care21 topic
  9. Coronavirus21 topic
  10. Erectile Dysfunction21 topic
  11. Infection Control Measures21 topic
  12. Neurologic Manifestations21 topic
  13. Post-acute COVID-19 Syndrome21 topic
  14. Sexual Dysfunction21 topic
  15. Sigma-1 Receptor21 topic
  16. Vaccine21 topic
  17. Breast Tumours11 topic
  18. Gene Expression11 topic

Where does Imran Lodhi work?

Imran Lodhi's main affiliation in the publication record is Reckitt Benckiser (United Kingdom), United Kingdom.

How many publications and citations does Imran Lodhi have?

OpenAlex counts 17 works and 296 citations for Imran Lodhi, an h-index of 7, ranking #3,936,051 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Imran Lodhi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.